T. Rowe Price Associates’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $743K | Buy |
|
|||||
|
2025
Q2 | $540K | Buy |
|
|||||
|
2025
Q1 | $475K | Buy |
|
|||||
|
2024
Q4 | $605K | Buy |
|
|||||
|
2024
Q3 | $595K | Buy |
|
|||||
|
2024
Q2 | $450K | Buy |
|
|||||
|
2024
Q1 | $400K | Buy |
|
|||||
|
2023
Q4 | $365K | Buy |
|
|||||
|
2023
Q3 | $279K | Buy |
|
|||||
|
2023
Q2 | $213K | Buy |
|
|||||
|
2023
Q1 | $348K | Buy |
|
|||||
|
2022
Q4 | $353K | Sell |
|
|||||
|
2022
Q3 | $433K | Buy |
|
|||||
|
2022
Q2 | $299K | Sell |
|
|||||
|
2022
Q1 | $613K | Buy |
|
|||||
|
2021
Q4 | $426K | Buy |
|
|||||
|
2021
Q3 | $448K | Buy |
|
|||||
|
2021
Q2 | $394K | Buy |
|
|||||
|
2021
Q1 | $314K | Buy |
|
|||||
|
2020
Q4 | $262K | Buy |
|